We could not find any results for:
Make sure your spelling is correct or try broadening your search.
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients healthcare prof... LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients healthcare professionals and healthcare systems. At LivaNova we understand the importance of bringing both clinical and economic value to our customers. We are a strong market-leading medical technology and services company offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol LIVN. LivaNova has approximately 3000 employees worldwide. We are headquartered in London UK and maintain a presence in more than 100 countries. LivaNova is a worldwide leader in advanced circulatory support cardiopulmonary and neuromodulation dedicated to creating meaningful products and therapies that transform lives each and every day. Show more
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time (8...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 (the...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its intention to offer $300 million aggregate principal amount of convertible senior notes due 2029 (the...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Barclays Global...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.38 | -2.56935393781 | 53.71 | 54.26 | 51.71 | 519718 | 52.87508008 | CS |
4 | -4.04 | -7.16693276566 | 56.37 | 56.715 | 51.71 | 541614 | 54.31990827 | CS |
12 | 2.28 | 4.55544455544 | 50.05 | 57.8 | 47.79 | 665086 | 53.46844925 | CS |
26 | 2.57 | 5.16479099678 | 49.76 | 57.8 | 42.75 | 595997 | 50.94382904 | CS |
52 | 4.63 | 9.70649895178 | 47.7 | 59.86 | 42.75 | 494668 | 51.2440951 | CS |
156 | -28.66 | -35.3870848253 | 80.99 | 93.89 | 40.26 | 431828 | 60.59120659 | CS |
260 | -14.09 | -21.2134899127 | 66.42 | 93.89 | 33.4 | 454382 | 61.19426192 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions